Zobrazeno 1 - 10
of 5 770
pro vyhledávání: '"Scoazec, JY"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Leclerc J; Department of Pathology, Centre Hospitalo-Universitaire de Rouen, Rouen, France., Tihy M; Department of Pathology, Hôpital Bichat, AP-HP, Paris, France., Genestie C; Department of Pathology, Institut Gustave Roussy, Villejuif, France., Chen R; Department of Pathology, Hôpital Bichat, AP-HP, Paris, France., Hentic O; Department of Pancreatology, Hôpital Beaujon, AP-HP, Clichy, France., Koskas M; Department of Gynecologic Surgery, Hôpital Bichat, AP-HP, Paris, France., Gouy S; Department of Gynecologic Surgery, Institut Gustave Roussy, Villejuif, France., Scoazec JY; Department of Pathology, Institut Gustave Roussy, Villejuif, France., Couvelard A; Department of Pathology, Hôpital Bichat, AP-HP, Paris, France., Bucau M; Department of Pathology, Hôpital Bichat, AP-HP, Paris, France.
Publikováno v:
International journal of surgical pathology [Int J Surg Pathol] 2024 Oct 07, pp. 10668969241271923. Date of Electronic Publication: 2024 Oct 07.
Autor:
Loriot Y; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; PRISM, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr., Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France. maud.kamal@gustaveroussy.fr., Syx L; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Nicolle R; Université Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, F-, 75018, Paris, France., Dupain C; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Mensourri N; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Duquesne I; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Lavaud P; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France., Nicotra C; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France., Ngocamus M; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France., Lacroix L; Biopath department, Gustave Roussy, Villejuif, France., Tselikas L; Department of interventional radiology, Gustave Roussy, Villejuif, France., Crehange G; Department of Radiothérapie, Institut Curie, 75005 Paris & 92210 Saint-Cloud, Paris, France., Friboulet L; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; PRISM, Gustave Roussy, Villejuif, France., Castel-Ajgal Z; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Neuzillet Y; Department of Urology, Foch Hospital, Suresnes, France., Borcoman E; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Beuzeboc P; Department of Urology, Foch Hospital, Suresnes, France., Marret G; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France., Gutman T; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Wong J; Department of Genetics, Institut Curie, 75005, Paris, France., Radvanyi F; UMR144, Institut Curie, 75005, Paris, France., Dureau S; Biometry unit, direction of clinical research, Institut Curie, 75005, Paris, France., Scoazec JY; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Biopath department, Gustave Roussy, Villejuif, France., Servant N; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Allory Y; Department of Pathology, Institut Curie, PSL Research University, 75005, Paris, France., Besse B; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Andre F; INSERM 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; PRISM, Gustave Roussy, Villejuif, France., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, 75005, Paris, France.; Bioinformatics and Computational Systems Biology of Cancer, Institut Curie, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France., Massard C; Gustave Roussy, DITEP, Gustave Roussy, Villejuif, France., Bieche I; Department of Genetics, Institut Curie, 75005, Paris, France.; INSERM U1016, Faculty of Pharmaceutical and Biological Sciences, Université Paris Cité, Paris, France.
Publikováno v:
Nature communications [Nat Commun] 2024 Oct 04; Vol. 15 (1), pp. 8603. Date of Electronic Publication: 2024 Oct 04.
Autor:
Vasseur D; Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; AMMICa UAR3655/US23, Gustave Roussy, Villejuif, France., Bigot L; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France., Beshiri K; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France., Flórez-Arango J; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France., Facchinetti F; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France., Hollebecque A; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France., Tselikas L; Department of Interventional Radiology, BIOTHERIS, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Aldea M; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France., Blanc-Durand F; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France., Gazzah A; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France., Planchard D; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France., Lacroix L; Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; AMMICa UAR3655/US23, Gustave Roussy, Villejuif, France., Pata-Merci N; AMMICa UAR3655/US23, Gustave Roussy, Villejuif, France., Nobre C; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France., Da Silva A; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France., Nicotra C; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France., Ngo-Camus M; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France., Braye F; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France., Nikolaev SI; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France., Michiels S; Université Paris-Saclay, CESP, InsermVillejuif, France.; Office of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France., Jules-Clement G; Bioinformatics Core Facility, Gustave Roussy, Université Paris-Saclay, CNRS UMS 3655, Inserm US23, Villejuif, France., Olaussen KA; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France., André F; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France., Scoazec JY; Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; AMMICa UAR3655/US23, Gustave Roussy, Villejuif, France., Barlesi F; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France., Ponce S; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France., Soria JC; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France., Besse B; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France., Loriot Y; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France. yohann.loriot@gustaveroussy.fr.; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr., Friboulet L; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France. luc.friboulet@gustaveroussy.fr.
Publikováno v:
Molecular cancer [Mol Cancer] 2024 Oct 04; Vol. 23 (1), pp. 221. Date of Electronic Publication: 2024 Oct 04.
Autor:
Gessain G; Institut Gustave Roussy, France., Anzali AA; Institut Gustave Roussy, France., Lerousseau M; Mines ParisTech, Paris, France., Mulder K; Institut Gustave Roussy, Villejuif, France., Bied M; Institut Gustave Roussy, France., Auperin A; Institut Gustave Roussy, Villejuif, France., Stockholm D; PSL Research University, Paris, France., Signolle N; Institut Gustave Roussy, Villejuif, France., Sassi F; Institut Gustave Roussy, France., Marques Da Costa ME; Gustave Roussy Cancer Institute, INSERM U1015, Université Paris-Saclay, Villejuif, France., Marchais A; Institut Gustave Roussy, Villejuif, France., Sayadi A; Beaujon Hospital, Clichy, France., Weidner D; Universitätsklinikum Erlangen, Germany., Uderhardt S; University Hospital Erlangen, Germany., Blampey Q; University of Paris-Saclay, Gif-sur-Yvette, 91190, France., Nakkireddy SR; Mayo Clinic, Jacksonville, Florida, United States., Broutin S; Institut Gustave Roussy, Villejuif, France., Dutertre CA; Institut Gustave Roussy, Paris, France., Busson P; CNRS - Gustave Roussy - Univ. Paris-Saclay, Villejuif, France., Walter T; Mines ParisTech, Paris, France., Marhic A; Institut Gustave Roussy, France., Moya-Plana A; Institut Gustave Roussy, France., Guerlain J; Institut Gustave Roussy, France., Breuskin I; Institut Gustave Roussy, Villejuif, France., Casiraghi O; Institut Gustave Roussy, Villejuif, France., Gorphe P; Institut Gustave Roussy, Villejuif, France., Classe M; Institut Gustave Roussy, France., Scoazec JY; Institut Gustave Roussy, Villejuif, Ile de France, France., Bleriot C; Institut Gustave Roussy, Villejuif, France., Ginhoux F; Singapore Immunology Network Agency for Science, Technology, and Research, Singapore, Singapore.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Sep 16. Date of Electronic Publication: 2024 Sep 16.
Autor:
Facchinetti F; Institut Gustave Roussy, Villejuif, France., Loriot Y; Institut de Cancérologie Gustave Roussy, Villejuif, France., Braye F; Institut Gustave Roussy, Villejuif, France., Vasseur D; Institut Gustave Roussy, Villejuif, France., Bahleda R; Institut Gustave Roussy, Villejuif, France., Bigot L; Institut Gustave Roussy, Villejuif, France., Barbé R; Institut Gustave Roussy, France., Nobre C; Institut Gustave Roussy, France., Combarel D; Institut Gustave Roussy, Villejuif, France., Michiels S; Institut Gustave Roussy, Villejuif, France., Italiano A; Institut Bergonié, Bordeaux, France., Smolenschi C; Institut Gustave Roussy, VILLEJUIF, France., Tselikas L; Institut Gustave Roussy, Villejuif, France., Scoazec JY; Institut Gustave Roussy, Villejuif, Ile de France, France., Ponce-Aix S; Institut Gustave Roussy, Villejuif, France., Besse B; Institut Gustave Roussy, Villejuif, France., Andre F; Institut Gustave Roussy, villejuif, France., Olaussen KA; University of Paris-Saclay, Villejuif, France., Hollebecque A; Institut Gustave Roussy, Villejuif, France., Friboulet L; Institut Gustave Roussy, Villejuif, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 03. Date of Electronic Publication: 2024 Sep 03.
Autor:
Dunsmore G; Institut Gustave Roussy, INSERM U1015, Bâtiment de Médecine Moléculaire 114 rue Edouard Vaillant, 94800 Villejuif, France.; Université Paris-Saclay, Ile-de-France, France., Guo W; Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Li Z; Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Bejarano DA; Quantitative Systems Biology, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany., Pai R; Curtin Medical School, Curtin University, Bentley, WA, Australia., Yang K; Singapore Immunology Network (SIgN), A*STAR, 8A Biomedical Grove, Immunos Building, Level 3, Singapore 138648, Singapore., Kwok I; Singapore Immunology Network (SIgN), A*STAR, 8A Biomedical Grove, Immunos Building, Level 3, Singapore 138648, Singapore., Tan L; Singapore Immunology Network (SIgN), A*STAR, 8A Biomedical Grove, Immunos Building, Level 3, Singapore 138648, Singapore., Ng M; Singapore Immunology Network (SIgN), A*STAR, 8A Biomedical Grove, Immunos Building, Level 3, Singapore 138648, Singapore., De La Calle Fabregat C; Institut Gustave Roussy, INSERM U1015, Bâtiment de Médecine Moléculaire 114 rue Edouard Vaillant, 94800 Villejuif, France., Yatim A; Institut Curie, PSL University, INSERM U932, Immunity and Cancer, 75005 Paris, France., Bougouin A; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC Université Paris Cité, Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France., Mulder K; Institut Gustave Roussy, INSERM U1015, Bâtiment de Médecine Moléculaire 114 rue Edouard Vaillant, 94800 Villejuif, France.; Université Paris-Saclay, Ile-de-France, France., Thomas J; Quantitative Systems Biology, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany., Villar J; Institut Gustave Roussy, INSERM U1015, Bâtiment de Médecine Moléculaire 114 rue Edouard Vaillant, 94800 Villejuif, France., Bied M; Institut Gustave Roussy, INSERM U1015, Bâtiment de Médecine Moléculaire 114 rue Edouard Vaillant, 94800 Villejuif, France.; Université Paris-Saclay, Ile-de-France, France., Kloeckner B; Institut Gustave Roussy, INSERM U1015, Bâtiment de Médecine Moléculaire 114 rue Edouard Vaillant, 94800 Villejuif, France.; Université Paris-Saclay, Ile-de-France, France., Dutertre CA; Institut Gustave Roussy, INSERM U1015, Bâtiment de Médecine Moléculaire 114 rue Edouard Vaillant, 94800 Villejuif, France., Gessain G; Institut Gustave Roussy, INSERM U1015, Bâtiment de Médecine Moléculaire 114 rue Edouard Vaillant, 94800 Villejuif, France., Chakarov S; Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Liu Z; Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Scoazec JY; Institut Gustave Roussy, INSERM U1015, Bâtiment de Médecine Moléculaire 114 rue Edouard Vaillant, 94800 Villejuif, France., Lennon-Dumenil AM; Institut Curie, PSL University, INSERM U932, Immunity and Cancer, 75005 Paris, France., Marichal T; Laboratory of Immunophysiology, GIGA Institute, Liège University, Liège, Belgium.; Faculty of Veterinary Medicine, Liège University, Liège, Belgium.; Walloon Excellence in Life Sciences and Biotechnology (WELBIO) Department, WEL Research Institute, Wavre, Belgium., Sautès-Fridman C; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC Université Paris Cité, Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France., Fridman WH; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC Université Paris Cité, Equipe Labellisée Ligue Nationale Contre le Cancer, Paris, France., Sharma A; Curtin Medical School, Curtin University, Bentley, WA, Australia.; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, 6 Verdun Street, Nedlands, Perth, WA 6009, Australia.; Institute of Molecular and Cellular Biology, A*STAR, Singapore 138673, Singapore.; KK Research Centre, KK Women's and Children's Hospital, Singapore 229899, Singapore.; Translational Genomics Program, Garvan Institute of Medical Research and Kinghorn Cancer Centre, Darlinghurst, NSW, Australia., Su B; Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Schlitzer A; Quantitative Systems Biology, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany., Ng LG; Shanghai Immune Therapy Institute Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200010, China.; Department of Microbiology and Immunology, National University of Singapore, Singapore, Singapore., Blériot C; Institut Gustave Roussy, INSERM U1015, Bâtiment de Médecine Moléculaire 114 rue Edouard Vaillant, 94800 Villejuif, France.; Institut Necker Enfants Malades (INEM), CNRS UMR 8253, INSERM U1151, 160 rue de Vaugirard, 75015 Paris, France., Ginhoux F; Institut Gustave Roussy, INSERM U1015, Bâtiment de Médecine Moléculaire 114 rue Edouard Vaillant, 94800 Villejuif, France.; Université Paris-Saclay, Ile-de-France, France.; Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.; Singapore Immunology Network (SIgN), A*STAR, 8A Biomedical Grove, Immunos Building, Level 3, Singapore 138648, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228 Singapore.
Publikováno v:
Science immunology [Sci Immunol] 2024 Jul 26; Vol. 9 (97), pp. eadk3981. Date of Electronic Publication: 2024 Jul 26.
Autor:
Ngo C; Department of Pathology and Laboratory Medicine, Gustave Roussy, Villejuif, France. Electronic address: carine.ngo@gustaveroussy.fr., Cotteret S; Department of Pathology and Laboratory Medicine, Gustave Roussy, Villejuif, France., Deneche I; Department of Statistics, Gustave Roussy, Villejuif, France., Kfoury M; Department of Gynaecological Oncology, Gustave Roussy, Villejuif, France., Chehab R; Department of Pathology and Laboratory Medicine, Gustave Roussy, Villejuif, France., Tran-Dien A; INSERM U981, Gustave Roussy, Villejuif, France., Vibert J; Department of Pathology and Laboratory Medicine, Gustave Roussy, Villejuif, France., Leary A; Department of Gynaecological Oncology, Gustave Roussy, Villejuif, France., Gouy S; Department of Gynaecological Oncology Surgery, Gustave Roussy, Villejuif, France., Maulard A; Department of Gynaecological Oncology Surgery, Gustave Roussy, Villejuif, France., Morice P; Department of Gynaecological Oncology Surgery, Gustave Roussy, Villejuif, France; Université Paris Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France., Scoazec JY; Department of Pathology and Laboratory Medicine, Gustave Roussy, Villejuif, France; Université Paris Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France., Pautier P; Department of Gynaecological Oncology, Gustave Roussy, Villejuif, France., Genestie C; Department of Pathology and Laboratory Medicine, Gustave Roussy, Villejuif, France.
Publikováno v:
Human pathology [Hum Pathol] 2024 Jun; Vol. 148, pp. 14-22. Date of Electronic Publication: 2024 Apr 28.
Autor:
Bigot L; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France., Sabio J; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France., Poiraudeau L; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France., Annereau M; Pharmacy, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Menssouri N; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France., Helissey C; Clinical Research Unit, Department of Oncology, Military Hospital Begin, Saint-Mandé, France., Déas O; XenTech, Evry, France., Aglave M; Plateforme de Bioinformatique, Gustave Roussy, Villejuif, France., Ibrahim T; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France., Pobel C; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France., Nobre C; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France., Nicotra C; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France., Ngo-Camus M; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France., Lacroix L; Experimental and Translational Pathology Platform (PETRA), Genomic Platform - Molecular Biopathology Unit (BMO) and Biological Resource Center, AMMICA, INSERM, Villejuif, France; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France., Rouleau E; Experimental and Translational Pathology Platform (PETRA), Genomic Platform - Molecular Biopathology Unit (BMO) and Biological Resource Center, AMMICA, INSERM, Villejuif, France; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France., Tselikas L; Department of Interventional Radiology, Gustave Roussy Cancer Campus, Villejuif, France., Judde JG; XenTech, Evry, France., Chauchereau A; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France., Bernard-Tessier A; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Patrikidou A; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Naoun N; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Flippot R; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Colomba E; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Fuerea A; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Albiges L; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Lavaud P; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Massard C; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France., Friboulet L; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France., Fizazi K; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Besse B; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France., Scoazec JY; Experimental and Translational Pathology Platform (PETRA), Genomic Platform - Molecular Biopathology Unit (BMO) and Biological Resource Center, AMMICA, INSERM, Villejuif, France; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France., Loriot Y; Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Inserm U981, Gustave Roussy Cancer, Université Paris-Saclay, Villejuif, France; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: yohann.loriot@gustaveroussy.fr.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2024 Jun; Vol. 7 (3), pp. 527-536. Date of Electronic Publication: 2023 Oct 27.
Autor:
Thuilliez C; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif F-94805, France., Moquin-Beaudry G; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif F-94805, France., Khneisser P; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif 94805, France., Marques Da Costa ME; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif F-94805, France.; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif 94805, France., Karkar S; University Bordeaux, CNRS, IBGC, UMR, Bordeaux 33077, France.; Bordeaux Bioinformatic Center CBiB, University of Bordeaux, Bordeaux 33000, France., Boudhouche H; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif F-94805, France., Drubay D; Office of Biostatistics and Epidemiology, Gustave Roussy, Université Paris-Saclay, Villejuif 94805, France.; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, Labeled Ligue Contre le Cancer, Villejuif 94805, France., Audinot B; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif F-94805, France., Geoerger B; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif F-94805, France.; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif 94805, France., Scoazec JY; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif 94805, France., Gaspar N; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif F-94805, France.; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif 94805, France., Marchais A; INSERM U1015, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif F-94805, France.; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif 94805, France.
Publikováno v:
Bioinformatics advances [Bioinform Adv] 2024 May 30; Vol. 4 (1), pp. vbae081. Date of Electronic Publication: 2024 May 30 (Print Publication: 2024).